超性心肌病:当前的前景
Dhruvil Patel1, Ruchika Bhargav1, Aliaa Mousa1
1Department of Cardiology, Rutgers Robert Wood Johnson University Hospital, New Brunswick, NJ 08901, USA.
Reviews in cardiovascular medicine
|October 15, 2025
概括
增高性心肌病变 (HCM) 是一种遗传性心脏病,每200-500人中就有1人患有这种疾病. 这篇评论探讨了它的遗传基础,通过成像诊断,以及超越传统治疗的新疗法.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 病理生理学 病理生理学
背景情况:
- 增高性心肌病变 (HCM) 是一种遗传性疾病,导致左心室增高 (LVH).
- 患病率估计范围从每200人中的1人到每500人中的1人.
- 目前正在进行的研究确定了新的突变和病理生理机制.
研究的目的:
- 系统地审查HCM的遗传和病理生理基础.
- 探索多模式成像在诊断和风险分层HCM患者中的作用.
- 检查当代的管理策略和新的治疗方法对HCM.
主要方法:
- 关于HCM的遗传和病理生理学研究的文献综述.
- 分析用于HCM诊断和风险分层的多模式成像技术.
- 检查当前和新兴的治疗策略对HCM.
主要成果:
- 已经确定了许多与HCM相关的致病突变.
- 多模式成像对于准确的诊断和风险分层至关重要.
- 针对分子机制的新疗法为治疗提供了新的途径.
结论:
- 人们对HCM的理解已经进化,导致了更精细的定义和认可.
- 先进的成像和遗传洞察力改善了患者管理.
- 新兴的向疗法为传统干预措施提供了替代方案,如肌切除术或隔膜切除.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
401
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
401
Cardiomyopathy V: Interprofessional Care
338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Cardiomyopathy I: Introduction and Classification
502
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
502
Cardiomyopathy II: Dilated Cardiomyopathy
468
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
468
Heart Failure II: Pathophysiology
722
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
722
Cardiomyopathy IV: Restrictive Cardiomyopathy
453
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
453


